https://www.selleckchem.com/pr....oducts/dansylcadaver
BACKGROUND Cannabis benefits patients with inflammatory bowel disease (IBD). Cannabinoid receptors are expressed in gut immune cells and in epithelial cells of inflamed guts. Mucosal healing (MH) requires epithelial layer restoration. OBJECTIVE To analyze the effects of CB2 agonist on parameters implicated in gut inflammation and MH. METHODS Mucosal samples from areas of inflamed/uninflamed colon from 16 patients with IBD were cultured without/with cannabinoid receptor 2 (CB2) agonist (JWH-133, 10 µM, 6 ho
Gefällt mir
Kommentar
Teilen
